Schedule 13G ownership disclosure

Bright Minds Biosciences Inc

Common Shares, without par value · CUSIP: 10919W405

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Commodore Capital LP

    Shares: 18,851.00 · Class: 0.3%

  • Commodore Capital Master LP

    Shares: 18,851.00 · Class: 0.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001831942-26-000007
Form type
SCHEDULE 13G/A
Filer
BRIGHT MINDS BIOSCIENCES INC.
CIK
CIK 1827401
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub